CHERNEY: Characteristics of participants enrolled in renal outcome trials involving SGLT2 inhibitors

EMPA-KIDNEY ⏳⌛️
🔲 +/- Type 2 DM (T2D)
🔲 eGFR ~ 20
🔲 Low levels of albuminuria
🇲🇾

👉 https://t.co/R8rVmrqwAf

20 35